These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26910107)

  • 1. Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial.
    Skov J; Pedersen M; Holst JJ; Madsen B; Goetze JP; Rittig S; Jonassen T; Frøkiaer J; Dejgaard A; Christiansen JS
    Diabetes Obes Metab; 2016 Jun; 18(6):581-9. PubMed ID: 26910107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
    Paulsen L; Holm C; Bech JN; Starklint J; Pedersen EB
    Nephrol Dial Transplant; 2008 May; 23(5):1556-61. PubMed ID: 18065809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prostacyclin on renal haemodynamics, renal tubular function and vasoactive hormones in healthy humans. A placebo-controlled dose-response study.
    Nielsen CB; Bech JN; Pedersen EB
    Br J Clin Pharmacol; 1997 Nov; 44(5):471-6. PubMed ID: 9384464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men.
    Skov J; Dejgaard A; Frøkiær J; Holst JJ; Jonassen T; Rittig S; Christiansen JS
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E664-71. PubMed ID: 23463656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes.
    Lovshin JA; Barnie A; DeAlmeida A; Logan A; Zinman B; Drucker DJ
    Diabetes Care; 2015 Jan; 38(1):132-9. PubMed ID: 25414155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
    Rousso P; Buclin T; Nussberger J; Décosterd LA; La Roche SD; Brunner-Ferber F; Brunner HR; Biollaz J
    J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
    Liakos A; Lambadiari V; Bargiota A; Kitsios K; Avramidis I; Kotsa K; Gerou S; Boura P; Tentolouris N; Dimitriadis G; Tsapas A
    Diabetes Obes Metab; 2019 Mar; 21(3):517-524. PubMed ID: 30242948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
    Eiskjaer H; Schmiegelow M; Jespersen B; Tietze IN; Jensen JD; Sørensen SS; Thomsen K; Pedersen EB
    Eur J Clin Pharmacol; 1991; 41(6):547-54. PubMed ID: 1840038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of BQ-123, an endothelin antagonist, on renal hemodynamics, tubular function, vasoactive hormones, and blood pressure in healthy humans: a dose response study.
    Pedersen EB; Thomsen IM; Fjordside LS
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1578-85. PubMed ID: 16364829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial.
    Tonneijck L; Smits MM; Muskiet MHA; Hoekstra T; Kramer MHH; Danser AHJ; Diamant M; Joles JA; van Raalte DH
    Diabetologia; 2016 Jul; 59(7):1412-1421. PubMed ID: 27038451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment.
    von Scholten BJ; Lajer M; Goetze JP; Persson F; Rossing P
    Diabet Med; 2015 Mar; 32(3):343-52. PubMed ID: 25251901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Tonneijck L; Smits MM; Muskiet MH; Hoekstra T; Kramer MH; Danser AH; Ter Wee PM; Diamant M; Joles JA; van Raalte DH
    Diabetes Care; 2016 Nov; 39(11):2042-2050. PubMed ID: 27585605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemodynamic and renal effects of glucagon-like peptide 1 analog and dipeptidyl peptidase-4 inhibitor in rats.
    Zhou X; Huang CH; Lao J; Pocai A; Forrest G; Price O; Roy S; Kelley DE; Sullivan KA; Forrest MJ
    Cardiovasc Diabetol; 2015 Mar; 14():29. PubMed ID: 25888997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of captopril on renal function in healthy uninephrectomized subjects and in healthy control subjects.
    Nielsen CB; Pedersen EB
    J Intern Med; 1994 Apr; 235(4):359-65. PubMed ID: 8151269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of GLP-1 based therapies on postprandial haemodynamics: Two randomised, placebo-controlled trials in overweight type 2 diabetes patients.
    Smits MM; Tonneijck L; Muskiet MH; Hoekstra T; Kramer MH; Diamant M; van Raalte DH
    Diabetes Res Clin Pract; 2017 Feb; 124():1-10. PubMed ID: 28086201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes.
    Mose FH; Larsen T; Jensen JM; Hansen AB; Bech JN; Pedersen EB
    Scand J Clin Lab Invest; 2014 Jan; 74(1):8-19. PubMed ID: 24256611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of liraglutide on renal function: A randomized clinical trial.
    von Scholten BJ; Persson F; Rosenlund S; Hovind P; Faber J; Hansen TW; Rossing P
    Diabetes Obes Metab; 2017 Feb; 19(2):239-247. PubMed ID: 27753201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normotensive sodium loading in normal man: regulation of renin secretion during beta-receptor blockade.
    Mølstrøm S; Larsen NH; Simonsen JA; Washington R; Bie P
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R436-45. PubMed ID: 19073901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal and endocrine effects of physiological variations of atrial natriuretic factor in normal humans.
    Bruun NE; Skøtt P; Giese J
    Am J Physiol; 1991 Jan; 260(1 Pt 2):R217-24. PubMed ID: 1847023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
    Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB
    Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.